Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.9702
+0.0792 (8.89%)
At close: May 30, 2025, 4:00 PM
0.9999
+0.0297 (3.06%)
After-hours: May 30, 2025, 7:44 PM EDT

RVPH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
8.187.898.085.365.252.14
Upgrade
Research & Development
21.2422.9131.4222.874.850.3
Upgrade
Operating Expenses
29.4130.839.528.2310.12.43
Upgrade
Operating Income
-29.41-30.8-39.5-28.23-10.1-2.43
Upgrade
Interest Expense
-0.03-0.02-0.03--0-1.45
Upgrade
Interest & Investment Income
0.270.360.40.18-0.08
Upgrade
Other Non Operating Income (Expenses)
0.270.56-0.1-0.191.590.03
Upgrade
Pretax Income
-28.9-29.9-39.24-28.24-8.52-3.78
Upgrade
Income Tax Expense
0.020.020.020.020.010
Upgrade
Net Income
-28.92-29.92-39.26-28.26-8.52-3.78
Upgrade
Net Income to Common
-28.92-29.92-39.26-28.26-8.52-3.78
Upgrade
Shares Outstanding (Basic)
38332420153
Upgrade
Shares Outstanding (Diluted)
38332420153
Upgrade
Shares Change (YoY)
46.59%39.28%21.94%31.95%383.10%10.60%
Upgrade
EPS (Basic)
-0.76-0.90-1.65-1.45-0.58-1.24
Upgrade
EPS (Diluted)
-0.76-0.90-1.65-1.45-0.58-1.24
Upgrade
EBITDA
-----10.1-2.43
Upgrade
D&A For EBITDA
----00
Upgrade
EBIT
-29.41-30.8-39.5-28.23-10.1-2.43
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q